George Ousler from Haverhill, MA

view source

Specialties:

Orthopaedic Surgery
Orthopaedic Surgery of the Hand

Education:

Thomas Jefferson University (1965)

view source

Position:

Director at ORA

Location:

Greater Boston Area

Industry:

Pharmaceuticals

Work:

ORA
Director

Education:

Trinity College-Hartford 1993 - 1997

Use Of Neurotransmitters And Neuropeptides For The Treatment Of Dry Eye Diseases And Related Conditions
view source
US Patent:

20060270592, Nov 30, 2006
Filed:

Dec 6, 2005
Appl. No.:

11/295165
Inventors:

George Ousler - North Andover MA, US
Matthew Chapin - Haverhill MA, US
Mark Abelson - Andover MA, US
Assignee:

Ophthalmic Research Associates, Inc. - North Andover MA
International Classification:

A61K 38/22
A61K 31/4172
A61K 31/198
A61K 31/137
A61K 31/195
US Classification:

514012000, 514400000, 514567000, 514561000, 514649000
Abstract:

The invention further features novel methods and compositions for treating and preventing dry eye by administration of neurotransmitters and/or neuropeptides, optionally in formulation with various other agents, as well as kits for the use of such novel formulations and methods.

Formulations And Methods For Treating Dry Eye
view source
US Patent:

20070254841, Nov 1, 2007
Filed:

Jan 25, 2007
Appl. No.:

11/698778
Inventors:

George Ousler - North Andover MA, US
Matthew Chapin - Haverhill MA, US
Mark Abelson - Andover MA, US
Assignee:

Ophthalmic Research Associates, Inc. - North Andover MA
International Classification:

A61K 38/00
A61K 31/01
A61K 31/045
A61K 31/21
A61K 31/40
A61K 31/715
US Classification:

514012000, 514413000, 514506000, 514059000, 514724000, 514762000
Abstract:

Provided are methods and compositions for treating and preventing dry eye and/or increasing tear film break-up time.

Formulations And Methods For Treating Dry Eye
view source
US Patent:

20070297981, Dec 27, 2007
Filed:

Jun 18, 2007
Appl. No.:

11/820461
Inventors:

George Ousler - North Andover MA, US
Matthew Chapin - Amesbury MA, US
Mark Abelson - Andover MA, US
International Classification:

A61K 49/00
A61K 31/133
A61K 31/192
A61K 31/196
A61K 31/381
A61K 31/403
A61P 29/00
C12N 9/99
A61P 27/04
A61K 31/405
A61K 31/717
A61K 31/721
A61K 38/02
US Classification:

424009100, 435184000, 514002000, 514413000, 514420000, 514448000, 514567000, 514057000, 514570000, 514059000, 514663000
Abstract:

The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye.

Formulations And Methods For Treating Dry Eye
view source
US Patent:

20070299124, Dec 27, 2007
Filed:

May 24, 2007
Appl. No.:

11/807147
Inventors:

George Ousler - North Andover MA, US
Matthew Chapin - Amesbury MA, US
Mark Abelson - Andover MA, US
International Classification:

A61K 31/407
A61K 31/165
A61K 31/192
A61K 31/196
A61P 27/04
A61P 29/00
A61P 27/02
A61K 31/381
A61K 31/405
US Classification:

514413000, 514420000, 514448000, 514567000, 514569000, 514570000, 514619000
Abstract:

The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye.

Formulations And Methods For Treating Dry Eye
view source
US Patent:

20080039398, Feb 14, 2008
Filed:

Aug 2, 2007
Appl. No.:

11/890030
Inventors:

George Ousler - North Andover MA, US
Matthew Chapin - Amesbury MA, US
Mark Abelson - Andover MA, US
International Classification:

A61K 38/00
A61K 31/01
A61K 31/045
A61K 31/21
A61P 27/04
A61K 31/40
A61K 31/715
A61K 31/717
US Classification:

514012000, 514413000, 514057000, 514648000, 514738000, 514762000
Abstract:

The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye.

Instillation Techniques For Ophthalmic Agents To Enhance Treatment Effect
view source
US Patent:

20020115587, Aug 22, 2002
Filed:

Feb 22, 2002
Appl. No.:

10/080873
Inventors:

Mark Abelson - Andover MA, US
George Ousler - Andover MA, US
International Classification:

A61K031/00
US Classification:

514/001000
Abstract:

The present invention provides methods for instilling an ophthalmic agent. One embodiment of a method according to the invention includes causing a patient to refrain from blinking for at least a specified period of time so as to effect the substantial break down of the patient's tear film covering the patient's eye and instilling an ophthalmic agent to the patient's eye.

view source

Friends:

Katie Brierley, Luke Tansill, Mike Pensa, Heidi Ousler, Brett Longo